Hook / Thesis
Celestica is no longer a background EMS player; it's an increasingly visible supplier to hyperscalers building AI infrastructure. Recent coverage and hyperscaler capex commitments suggest a 2027 revenue and margin inflection that the market still underestimates. That sets up a trade where a measured entry into the stock captures upside from structural AI spending while limiting downside with a tight stop.
In short: buy on a near-term pullback into the $318 area, target a re-rate into the $380s if AI-driven server rack and systems work meaningfully accelerates into 2027, and use a stop below $300 to protect capital. The case is fundamentally driven - not momentum alone - and is supported by solid cash generation and exceptional return on equity.
What the company does and why investors should care
Celestica is a global supply chain and manufacturing partner serving two main segments: Advanced Technology Solutions (ATS) and Connectivity and Cloud Solutions (CCS). The latter includes enterprise communications, telecom, servers and storage - the parts of the business that benefit directly from hyperscaler and AI infrastructure spending.
Why the market should care: hyperscalers are committing large, multi-year pools of capital to AI infrastructure. Recent reporting shows hyperscaler cohorts planning hundreds of billions of dollars in cumulative infrastructure spending, with specific deals (like the Anthropic commitments reported 06/07/2026) directing tens of billions through cloud providers. Celestica sits in the middle of that supply chain - assembling custom racks and systems, integrating advanced compute modules, and provisioning at scale.
Numbers that matter
- Market capitalization is approximately $40.5 billion.
- Enterprise value sits near $39.67 billion, implying the market is valuing Celestica more on operating performance than balance-sheet leverage.
- Reported free cash flow was roughly $518.7 million (most recent metric available), while price-to-free-cash-flow sits near 76x on headline math.
- Return on equity is very strong at ~45%, with return on assets roughly 11.4%.
- Valuation multiples show a premium stance: price-to-earnings around ~32 (snapshot) and price-to-sales roughly 2.53.
- Share price technicals are constructive: 10-day SMA ~$304, 20-day SMA ~$311, 50-day SMA ~$327, and RSI around 52 with a bullish MACD histogram, suggesting room to run if momentum re-accelerates.
How the investment thesis connects to earnings and margins
The real lever for Celestica is margin expansion from higher content and system-level integration work tied to AI racks and servers. Industry reports and company commentary point to rapidly growing AI revenues - recent media pieces cited AI-related revenue growth in the 60% range year-over-year for Celestica. If Celestica can convert incremental hyperscaler demand into higher gross margin systems and recurring services, the expensive headline multiples start to make sense:
- High ROE indicates the business converts revenues into meaningful shareholder returns today.
- Free cash flow generation near $520 million provides the cash runway to invest in capacity and capture hyperscaler programs without diluting shareholders.
- Debt is modest: debt-to-equity is ~0.33, leaving room for disciplined capital spending rather than leverage-fueled growth.
Valuation framing
On headline multiples Celestica is rich: a P/E in the low 30s and a P/FCF north of 70x demand a growth profile that meaningfully improves margins or sales over the next 12-24 months. That is exactly the scenario the market is underpricing: a 2027 inflection where AI systems work becomes a larger revenue contributor and lifts consolidated margins and FCF conversion.
Think of valuation as a two-part equation: current profitability is high (ROE 45%), but the denominator (earnings and FCF) needs to grow to justify current multiples. A successful ramp of hyperscaler programs in 2027 that drives even mid-single-digit expansion in operating margins would materially narrow the premium implied by current multiples.
Catalysts
- Hyperscaler win announcements and program ramps - visible multi-year procurement commitments to Celestica would act as a clear catalyst.
- Quarterly revenue disclosures showing outsized AI-related revenue growth and improving gross margins.
- Public hyperscaler capex updates (e.g., large deals tied to Anthropic or other major AI projects) that confirm continued multi-hundred-billion-dollar infrastructure budgets.
- Guidance raises or analyst estimate upgrades reflecting a 2027 acceleration in systems-level work.
Trade plan (actionable)
Thesis: Celestica will re-rate into 2027 as AI systems work becomes a larger share of revenue and lifts margins. The trade is structured to buy a probable inflection while controlling downside.
- Trade direction: Long.
- Entry price: $318.00 (look to scale in or execute a limit order near today's intraday low to improve risk/reward).
- Stop loss: $300.00 (protects capital against a failed breakout or a broader tech drawdown).
- Target price: $380.00 (this represents disciplined upside that assumes margin expansion and continued AI revenue acceleration into 2027).
- Horizon: long term (180 trading days) - expect the campaign to play out over the next 4-6 quarters as hyperscaler programs ramp and the market discounts the 2027 earnings power.
Also consider smaller profit-taking milestones at $340 and $360 to de-risk the position as progress is confirmed.
Risks and counterarguments
- Execution risk: converting hyperscaler program wins into profitable revenue at scale is operationally difficult. Ramp delays, integration issues or warranty/service costs could compress margins despite higher sales.
- Concentration and customer mix: a handful of hyperscalers account for a disproportionate share of infrastructure spend. A single large customer pushout would materially impact Celestica’s revenue trajectory.
- Valuation risk: current multiples imply strong growth. If AI infrastructure demand cools or competitors win share, downside could be rapid and steep given the P/FCF and P/E levels.
- Supply chain and geo-political disruption: component shortages, tariff actions, or factory disruptions in key regions could delay deliveries just as hyperscalers demand rapid deployment.
- Counterargument - macro-driven capex cuts: one credible counter to the thesis is that macro weakness or a re-prioritization of AI spending could push hyperscalers to delay non-essential capacity, compressing Celestica's projected 2027 ramp. In that scenario, the valuation premium would unwind quickly.
What would change my mind
I would materially downgrade the thesis if any two of the following occur: (1) management discloses meaningful customer concentration risk without credible diversification plans; (2) quarterly revenue and margin trajectory show sequential declines for two straight quarters; or (3) public disclosures from major hyperscalers indicate a sustained reduction in AI infrastructure commitments. Conversely, visible large-scale program awards that include margin-accretive systems work would strengthen the bull case and could justify raising the target.
Conclusion
Celestica offers a clear thematic play on AI infrastructure with a credible path to a 2027 inflection. The stock is not cheap, but high ROE, substantial free cash flow, modest leverage and a visible addressable market make a disciplined long trade attractive. Enter near $318 with a $300 stop and $380 target for a long-term (180 trading days) campaign; trim into strength and watch hyperscaler program disclosures closely. The trade balances upside from an underappreciated AI revenue runway against tangible execution and valuation risks.
Key near-term things to watch: program announcements, quarterly margin beats, and hyperscaler capex updates - they will determine if Celestica’s 2027 inflection becomes reality.